Full Text (PDF)
Review Article

Covid 19 Era and Cardiovascular Short Term & Long Term Complications

Naresh Sen, Sonal Tanwar

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Journal of Cardiovascular Medicine and Surgery 8(2):p 55-59, APRIL-JUNE 2022. | DOI: https://doi.org/10.21088/jcms.2454.7123.8222.6

How Cite This Article:

Naresh Sen, Sonal Tanwar/Covid 19 Era and Cardiovascular Short Term & Long Term Complications/J Cardiovasc Med Surg.2022;8(2): 55-59.

Timeline

Received : April 01, 2022         Accepted : May 06, 2022          Published : June 30, 2022

Abstract

We are facing the worst pandemic of this 21st century in form of corona virus disease or COVID 19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), initially presented as respiratory system disorders, but later on COVID-19 has been revealed to adversely related the cardiovascular system resulting to myocardial injury and dysfunction of endothelium mainly via the angiotensin converting enzyme 2 (ACE-2) receptor.1 COVID-19 affects the cardiovascular system in manner of both the short term by acute injury and long term by the chronic consequences. Seasonally the new variant of COVID 19 are recognizing globally since December 2019.2 Recently new variant like Omicron variant found with multiple mutant spikes which may be highly toxic or virulent. We are going to review our focus, scanning and realizing to update acute and chronic cardiovascular complications of COVID 19. Emergence of new variants and time being delay until herd immunity will be alarming for managing consequences of acute viral infection, however many vaccines are available, and mostly population are vaccinated for protection from different variants for future survival.3 Approach of an integrated health system with COVID 19 behaviour, integrated yoga approach for better immunity and vaccines are hopeful weapons to fight COVID 19 era followed by gene therapy or stem cell therapy for good future to avoid long term cardio vascular complications.4,5


References

  • 1.   Gupta A, Madhavan MV, Sehgal K (2020) Extrapulmonary manifestations of COVID-19. Nat Med. https://doi.org/10.1038/s41591-020-0968-3
  • 2.   Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270–273
  • 3.   WHO Coronavirus (COVID-19) Dashboard|WHO Coronavirus (COVID-19) Dashboard with Vaccination Data [Internet]. [cited 2021 Aug 8]. https://covid19.who.int/
  • 4.   Dr. Naresh Sen, Dr.SonalTanwar. Integrated broad spectrum approach and combined strategy of world health system with public support to break pandemic Coronavirus disease (COVID-19). International Journal of Medical and Health Research, Volume 6, Issue 4, 2020, Pages 10-13
  • 5.   Naresh Sen. “Stem Cells Therapy in Cardiac Disorders Like Myocardial Infarction and Heart Failure Could be Great Future After Covid 19 Era”. EC Cardiology 8.10 (2021): 20.
  • 6.   Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O (2020) Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol 5:831–840
  • 7.   Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A et al (2020) COVID-19 and cardiovascular disease. Circulation 141(20):1648– 1655
  • 8.   Mahajan K, Chandra KS (2020) Cardiovascular comorbidities and complications associated with coronavirus disease 2019. Med J Armed Forces India 76:253–260
  • 9.   Dr. Naresh Sen, Dr. Sonal Tanwar. Integrated broad spectrum approach and combined strategy of world health system with public support to break pandemic Coronavirus disease (COVID-19). International Journal of Medical and Health Research, Volume 6, Issue 4, 2020, Pages 10-13

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Naresh Sen, Sonal Tanwar/Covid 19 Era and Cardiovascular Short Term & Long Term Complications/J Cardiovasc Med Surg.2022;8(2): 55-59.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
April 01, 2022 May 06, 2022 June 30, 2022

DOI: https://doi.org/10.21088/jcms.2454.7123.8222.6

Keywords

COVID 19 and VariantsCardiovascular disorders

Article Level Metrics

Last Updated

Monday 28 September 2026, 16:16:52 (IST)


1823

Accesses

8
242
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received April 01, 2022
Accepted May 06, 2022
Published June 30, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share